SUMO: a (oxidative) Stressed Protein

Overview

Journal Neuromolecular Med

Specialty Biochemistry

Date 2013 Sep 21

PMID 24052421

Citations 30

Authors

Marco Feligioni

Robert Nistico

Affiliations

Soon will be listed here.

Abstract

Redox species are produced during the physiological cellular metabolism of a normal tissue. In turn, their presence is also attributed to pathological conditions including neurodegenerative diseases. Many are the molecular changes that occur during the unbalance of the redox homeostasis. Interestingly, posttranslational protein modifications (PTMs) play a remarkable role. In fact, several target proteins are modified in their activation, localization, aggregation, and expression after the cellular stress. Among PTMs, protein SUMOylation represents a very important molecular modification pathway during "oxidative stress". It has been reported that this ubiquitin-like modification is a fine sensor for redox species. Indeed, SUMOylation pathway efficiency is affected by the exposure to oxidative species in a different manner depending on the concentration and time of application. Thus, we here report updated evidence that states the role of SUMOylation in several pathological conditions, and we also outline the key involvement of c-Jun N-terminal kinase and small ubiquitin modifier pathway cross talk.

Citing Articles

Protein modification in neurodegenerative diseases.

Ramazi S, Dadzadi M, Darvazi M, Seddigh N, Allahverdi A MedComm (2020). 2024; 5(8):e674.

PMID: 39105197 PMC: 11298556. DOI: 10.1002/mco2.674.

SumoPred-PLM: human SUMOylation and SUMO2/3 sites Prediction using Pre-trained Protein Language Model.

Palacios A, Acharya P, Peidl A, Beck M, Blanco E, Mishra A NAR Genom Bioinform. 2024; 6(1):lqae011.

PMID: 38327870 PMC: 10849187. DOI: 10.1093/nargab/lqae011.

Oxidative stress in pituitary neuroendocrine tumors: Affecting the tumor microenvironment and becoming a new target for pituitary neuroendocrine tumor therapy.

Zhou Y, Zhang A, Fang C, Yuan L, Shao A, Xu Y CNS Neurosci Ther. 2023; 29(10):2744-2759.

PMID: 37341156 PMC: 10493678. DOI: 10.1111/cns.14315.

Clinical relevance of biomarkers, new therapeutic approaches, and role of post-translational modifications in the pathogenesis of Alzheimer's disease.

Mumtaz I, Ayaz M, Khan M, Manzoor U, Ganayee M, Bhat A Front Aging Neurosci. 2022; 14:977411.

PMID: 36158539 PMC: 9490081. DOI: 10.3389/fnagi.2022.977411.

Protective Effect of Curcuma Extract in an Model of Retinal Degeneration via Antioxidant Activity and Targeting the SUMOylation.

Hassanzadeh K, Vahabzadeh Z, Bucarello L, Dragotto J, Corbo M, Maccarone R Oxid Med Cell Longev. 2022; 2022:8923615.

PMID: 35941902 PMC: 9356244. DOI: 10.1155/2022/8923615.

References

Zhao J . Sumoylation regulates diverse biological processes. Cell Mol Life Sci. 2007; 64(23):3017-33. PMC: 7079795. DOI: 10.1007/s00018-007-7137-4. View

Cadenas E, Davies K . Mitochondrial free radical generation, oxidative stress, and aging. Free Radic Biol Med. 2000; 29(3-4):222-30. DOI: 10.1016/s0891-5849(00)00317-8. View

Lee Y, Jang M, Lee J, Choi E, Kim E . SUMO-1 represses apoptosis signal-regulating kinase 1 activation through physical interaction and not through covalent modification. EMBO Rep. 2005; 6(10):949-55. PMC: 1369187. DOI: 10.1038/sj.embor.7400511. View

Tsutsui H, Kinugawa S, Matsushima S . Oxidative stress and heart failure. Am J Physiol Heart Circ Physiol. 2011; 301(6):H2181-90. DOI: 10.1152/ajpheart.00554.2011. View

Trigueros-Motos L, Gonzalez J, Rivera J, Andres V . Hutchinson-Gilford progeria syndrome, cardiovascular disease and oxidative stress. Front Biosci (Schol Ed). 2011; 3(4):1285-97. DOI: 10.2741/226. View

Matunis M, Coutavas E, Blobel G . A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex. J Cell Biol. 1996; 135(6 Pt 1):1457-70. PMC: 2133973. DOI: 10.1083/jcb.135.6.1457. View

Boggio R, Colombo R, Hay R, Draetta G, Chiocca S . A mechanism for inhibiting the SUMO pathway. Mol Cell. 2004; 16(4):549-61. DOI: 10.1016/j.molcel.2004.11.007. View

Behrens A, Sibilia M, Wagner E . Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation. Nat Genet. 1999; 21(3):326-9. DOI: 10.1038/6854. View

Elsasser S, Gali R, Schwickart M, Larsen C, Leggett D, Muller B . Proteasome subunit Rpn1 binds ubiquitin-like protein domains. Nat Cell Biol. 2002; 4(9):725-30. DOI: 10.1038/ncb845. View

10.

Gareau J, Lima C . The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition. Nat Rev Mol Cell Biol. 2010; 11(12):861-71. PMC: 3079294. DOI: 10.1038/nrm3011. View

11.

Huang H, Du G, Chen H, Liang X, Li C, Zhu N . Drosophila Smt3 negatively regulates JNK signaling through sequestering Hipk in the nucleus. Development. 2011; 138(12):2477-85. DOI: 10.1242/dev.061770. View

12.

Huang J, Berger S . The emerging field of dynamic lysine methylation of non-histone proteins. Curr Opin Genet Dev. 2008; 18(2):152-8. DOI: 10.1016/j.gde.2008.01.012. View

13.

Feligioni M, Brambilla E, Camassa A, Sclip A, Arnaboldi A, Morelli F . Crosstalk between JNK and SUMO signaling pathways: deSUMOylation is protective against H2O2-induced cell injury. PLoS One. 2011; 6(12):e28185. PMC: 3229511. DOI: 10.1371/journal.pone.0028185. View

14.

Patel V, Chu C . Nuclear transport, oxidative stress, and neurodegeneration. Int J Clin Exp Pathol. 2011; 4(3):215-29. PMC: 3071655. View

15.

Foran E, Bogush A, Goffredo M, Roncaglia P, Gustincich S, Pasinelli P . Motor neuron impairment mediated by a sumoylated fragment of the glial glutamate transporter EAAT2. Glia. 2011; 59(11):1719-31. PMC: 3896305. DOI: 10.1002/glia.21218. View

16.

McLennan Y, Polussa J, Tassone F, Hagerman R . Fragile x syndrome. Curr Genomics. 2011; 12(3):216-24. PMC: 3137006. DOI: 10.2174/138920211795677886. View

17.

Navascues J, Bengoechea R, Tapia O, Vaque J, Lafarga M, Berciano M . Characterization of a new SUMO-1 nuclear body (SNB) enriched in pCREB, CBP, c-Jun in neuron-like UR61 cells. Chromosoma. 2007; 116(5):441-51. DOI: 10.1007/s00412-007-0107-7. View

18.

Kuan C, Yang D, Samanta Roy D, Davis R, Rakic P, Flavell R . The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron. 1999; 22(4):667-76. DOI: 10.1016/s0896-6273(00)80727-8. View

19.

Rodriguez M, Dargemont C, Hay R . SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting. J Biol Chem. 2001; 276(16):12654-9. DOI: 10.1074/jbc.M009476200. View

20.

Singh U, Jialal I . Oxidative stress and atherosclerosis. Pathophysiology. 2006; 13(3):129-42. DOI: 10.1016/j.pathophys.2006.05.002. View